Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

Denecimig (Mim8) tiered dosing achieves consistent exposure and bleed control in phase 3 FRONTIER studies

Authors :

Wan Hui Ong Clausen1, Julien Bovet2, Mads Kreilgaard3

Affiliations
View Details Hide Details
Download poster (.pdf)
Keywords
Rare Blood Disorders
Congress poster
Mim8